Promoting Radon Testing Among Mothers of Young Children
Radon is the second-leading cause of lung cancer after smoking and may contribute to other cancer deaths; children are especially vulnerable due to a larger lung surface area and higher respiratory rates. The goal of this research is to test the feasibility of the radon app to promote radon testing among mothers of children aged 4 or younger when they receive a free radon test kit.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated May 15, 2026 · Source: ClinicalTrials.gov
The study is currently accepting participants.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Prevention
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- University of North Dakota
- Interventions being studied
- Behavioral: The radon app
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Participants are female mothers of children aged 4 and under.
- Participants own a smartphone.
- Children brought in for appointments are their biological or adoptive child.
- Previous testing for radon within the past two (2) years.
- The mother's child brought in for the appointment is over 4 years of age.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of North Dakota Center for Family Medicine, Bismarck ClinicBismarck, North Dakota
- University of North Dakota Center for Family Medicine, Minot ClinicMinot, North Dakota
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 15, 2026. Always confirm current availability with the study team.